A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia

Update Il y a 5 ans
Reference: NCT02880462

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The goal of the study is to investigate whether adding different doses of sulforaphane will benefit the clinical symptoms and cognitive function in individuals who have schizophrenia. This study will compare the sulforaphane with placebo. There is a thirty percent change (less than half) of receiving the placebo. The purpose of including placebo is to judge if the outcome is related to the study medication rather than other reasons.


Inclusion criteria

  • Schizophrenia

Links